Acs, Balazs http://orcid.org/0000-0002-0972-4633
Ahmed, Fahad Shabbir http://orcid.org/0000-0002-5857-5478
Gupta, Swati
Wong, Pok Fai
Gartrell, Robyn D.
Sarin Pradhan, Jaya
Rizk, Emanuelle M.
Gould Rothberg, Bonnie
Saenger, Yvonne M.
Rimm, David L. http://orcid.org/0000-0001-5820-4397
Funding for this research was provided by:
Fulbright Association
Gruber Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute (KL2TR001874, P30CA016359)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Breast Cancer Research Foundation
Navigate biopharma Swim across America
Article History
Received: 11 April 2019
Accepted: 15 October 2019
First Online: 29 November 2019
Competing interests
: D.L.R. declares that he has served a consultant, advisor and/or servee on a Scientific Advisory Board for Amgen, Astra Zeneca, Agendia, Biocept, BMS, Cell Signaling Technology, Cepheid, Daiichi Sankyo, GSK, InVicro/Konica Minolta, Merck, NanoString, Perkin Elmer, PAIGE.AI, and Ultivue. He holds equity in PixelGear (start-up company related to direct tissue imaging) and Astra Zeneca, Cepheid, Navigate/Novartis, NextCure, Lilly, Ultivue, Ventana and Perkin Elmer/Akoya fund research in his lab. The remaining authors declare no competing interests.